Previous studies have reported that BMPR2 gene mutation in PAH is significantly downregulated, and the present study revealed that BMPR2 was targeted by i-tRF-31:54-Val-CAC-1. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.